Dept. of Radiation Oncology, Wayne State University, Detroit, MI 48201-2013, USA.
Radiother Oncol. 2011 Oct;101(1):233-6. doi: 10.1016/j.radonc.2011.05.068. Epub 2011 Jul 1.
Systems are being developed to assess radiation exposure based on leukocyte mRNA levels obtained by finger-stick sampling. The goal is to provide accurate detection of dose exposures up to 10 Gy for up to 1 week following exposure. We previously showed that specific mRNA sequences increase expression within an hour of exposure, and some genes continue to show elevated expression for at least 24 h. Full duration and dose-dependence of this persistence remain to be determined. In the present study, real-time quantitative PCR (qPCR) was used to determine changes in gene expression. qPCR can rapidly analyze small blood samples and could be adopted into a field-portable instrument that provides a radiation dose readout within 30 min.
From previous microarray analysis of 21,000 genes expressed in human lymphoblastoid cells 4 h post-irradiation (0-4 Gy), 118 genes were selected for evaluation by qPCR of gene expression in the leukocytes of human blood irradiated in vitro with doses of 0-10 Gy from a Co-60 gamma source at a dose rate of 30 cGy/min.
Blood from 20 normal healthy human donors yielded many mRNA sequences that could be used for radiation dosimetry. We observed four genes with large and persistent responses following exposure: ASTN2, CDKN1A, GADD45A, and GDF15. Five genes were identified as reliably non-responsive and were suitable for use as endogenous controls: DPM1, ITFG1, MAP4, PGK1, and SLC25A36; of these, ITFG1 was used for the analyses presented here. A significant dose-responsive increase in expression occurred for CDKN1A that was >16-fold at 10 Gy and 3-fold at 0.5 Gy compared to pre-irradiation values.
These data show large, selective increases in mRNA transcript levels that persist for at least 48 h after single exposures between 0.5 and 10 Gy. Stable, non-responsive mRNA sequences for use as endogenous controls were also identified. These results indicate that following further study to establish the most reproducible gene and dose-response models under a wide range of conditions in vivo, rapid real-time qPCR on blood samples could potentially be used to establish biologically-effective dosimetry from either accidental irradiation or clinical radiotherapy.
目前正在开发基于手指针刺取样获得的白细胞 mRNA 水平来评估辐射暴露的系统。其目标是提供准确的检测,以便在暴露后长达 1 周内检测到高达 10Gy 的剂量暴露。我们之前已经表明,特定的 mRNA 序列在暴露后 1 小时内增加表达,并且一些基因至少在 24 小时内持续表达升高。这种持续时间和剂量依赖性尚待确定。在本研究中,实时定量 PCR(qPCR) 用于确定基因表达的变化。qPCR 可以快速分析小的血液样本,并可以采用到一种现场便携式仪器中,该仪器可以在 30 分钟内提供辐射剂量读数。
从先前对人类淋巴母细胞系照射后 4 小时(0-4Gy)表达的 21000 个基因的微阵列分析中,选择了 118 个基因,通过 Co-60 伽马源在 30cGy/min 的剂量率下对体外照射 0-10Gy 的人血白细胞的基因表达进行 qPCR 评估。
来自 20 名正常健康人类供体的血液产生了许多可用于辐射剂量测定的 mRNA 序列。我们观察到,暴露后有四个基因表现出大且持续的反应:ASTN2、CDKN1A、GADD45A 和 GDF15。确定了五个基因作为可靠的非反应性基因,适用于作为内源性对照:DPM1、ITFG1、MAP4、PGK1 和 SLC25A36;其中,ITFG1 用于此处呈现的分析。在 10Gy 时,CDKN1A 的表达水平显著增加了 16 倍以上,而在 0.5Gy 时增加了 3 倍,与照射前的值相比。
这些数据表明,在 0.5 至 10Gy 之间单次照射后,mRNA 转录本水平会持续至少 48 小时出现较大的选择性增加。还确定了稳定的、非反应性的 mRNA 序列,可用作内源性对照。这些结果表明,在进一步研究以建立在体内广泛条件下最具重现性的基因和剂量反应模型之后,对血液样本进行快速实时 qPCR 可能有潜力用于从意外照射或临床放射治疗中建立生物有效剂量测定。